SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ARDT

Ardent Health, Inc. (New York Stock Exchange:ARDT)

US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
$15.08+$0.58 (+4.00%)
 
Market cap
$2.13B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 18, 2024
Market Cap$2.13B+69.8%
Revenue (ttm)$6.45B+2.0%
Net Income$146.22M-28.7%
EPS$1.03-31.3%
Shares Out140.94M
PE Ratio14.50
Forward PE11.98
Dividendn/a
Ex-Dividend Daten/a
Volume1,540,904
Open$14.40
Previous Close$14.50
Day's Range$14.37 - $15.14
52-Week Range$7.71 - $18.57
Beta0.72
AnalystsBuy
Price Target$14.60(-3.18%)
Earnings DateMar 3, 2027

About ARDT

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Address
340 Seven Springs Way, Brentwood, TN, 37027, US
Market Cap
2.13 billion
Employees
22,350
Industrial Classification
Medical - Care Facilities

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$186.40K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
3 Buy0 Hold0 SellAvg target $14.60 (-3.2%)

3 firms rating ARDT in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From ARDT’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+4.00%
5 Days
-16.45%
1 Month
+22.01%
6 Months
+63.38%
1 Year
+69.82%

$ARDT stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ARDT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ARDT's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ARDT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

ARDT Revenue by Segment

$1.62BTotal
Net patient service revenue$1.60B98.28%
Other revenue$28.00M1.72%
Percentage of revenue$1.00K0.00%
Other revenue, percentage of revenue$170.00%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New ARDT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ARDT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ARDT

AVUVAvantis U.S. Small Cap Value ETF$13.70M
IWMiShares Russell 2000 ETF$10.00M
BSVOEA Bridgeway Omni Small-Cap Value ETF$8.66M
VTIVanguard Morningstar Total Stock Market ETF$8.50M
FYXFirst Trust Small Cap Core AlphaDEX Fund$4.95M
DFSVU.S. Small Cap Value Portfolio ETF Class Shares$3.78M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from ARDT’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
31.46
Analyst Ratings
32% of score
80
News & Sentiment
20% of score
58

News check: Mixed coverage: acquisition and safety accolades offset by dilutive secondary offering; concrete business developments show execution despite near-term stock pressure.

Recent Insider Activity

Buys
2
Sells
0
Buy Value
$186.40K
Distinct Buyers
2

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

LITLSimplify Piper Sandler US Small-Cap PLUS Income ETF0.80%
FYTFirst Trust Small Cap Value AlphaDEX Fund0.75%
SVALiShares US Small Cap Value Factor ETF0.73%
IVSSApplied Finance IVS US SMID ETF0.50%
EESWisdomTree U.S. SmallCap Fund0.44%
BSVOEA Bridgeway Omni Small-Cap Value ETF0.41%
FYXFirst Trust Small Cap Core AlphaDEX Fund0.38%
EBITHarbor AlphaEdge Small Cap Earners ETF (EBIT)0.30%
XHYHBondBloxx USD High Yield Bond Healthcare Sector ETF0.24%
FABFirst Trust Multi Cap Value AlphaDEX Fund0.16%
VFMFVanguard U.S. Multifactor ETF0.09%
IQESInvesco U.S. Small Cap Enhanced ETF0.08%

Weight is the stock’s share of each fund’s holdings.